Michael A Farrar (Michael A Linden)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 16

Top Venues

Journal of immunology (Baltimore, Md. : 1950)

Nature communications

Nature immunology

Molecular cancer research : MCR

University of Minnesota System

Washington University in Saint Louis (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Minnesota System Jun 05 2000

United States

Professor :: Laboratory Medicine and Pathology

Merck Research Rahway Aug 01 1997 - May 31 2000

United States

Postdoctoral Fellow :: Immunology

University of Washington Aug 01 1993 - Jul 31 1997

United States

Postdoctoral fellow :: Immunology

Education History

Washington University in Saint Louis Sep 01 1987 - Jan 15 1993

United States

PHD :: Immunology

University of Wisconsin Madison Sep 01 1982 - May 14 1987

United States

BSC

Publications

Natalie A David, Robin D Lee, Rebecca S LaRue, Sookyong Joo, Michael A Farrar
Nuclear corepressors NCOR1 and NCOR2 entrain thymocyte signaling, selection, and emigration. bioRxiv : the preprint server for biology (2023)
Sean I Tracy, Hrishi Venkatesh, Can Hekim, Lynn M Heltemes-Harris, Todd P Knutson, Veronika Bachanova, Michael A Farrar
Combining nilotinib and PD-L1 blockade reverses CD4+ T-cell dysfunction and prevents relapse in acute B-cell leukemia. Blood 140 (4) (2022)
Robin D Lee, Todd P Knutson, Sarah A Munro, Jeffrey T Miller, Lynn M Heltemes-Harris, Charles G Mullighan, Kristen Jepsen, Michael A Farrar
Nuclear corepressors NCOR1/NCOR2 regulate B cell development, maintain genomic integrity and prevent transformation. Nature immunology (2022)
David L Owen, Rebecca S La Rue, Sarah A Munro, Michael A Farrar
Tracking Regulatory T Cell Development in the Thymus Using Single-Cell RNA Sequencing/TCR Sequencing. Journal of immunology (Baltimore, Md. : 1950) 209 (7) (2022)
Robin D Lee, Sarah A Munro, Todd P Knutson, Rebecca S LaRue, Lynn M Heltemes-Harris, Michael A Farrar
Single-cell analysis identifies dynamic gene expression networks that govern B cell development and transformation. Nature communications 12 (1) (2021)
Lynn M Heltemes-Harris, Gregory K Hubbard, Rebecca S LaRue, Sarah A Munro, Rendong Yang, Christine M Henzler, Timothy K Starr, Aaron L Sarver, Steven Mitchell Kornblau, Michael A Farrar
Identification of mutations that cooperate with defects in B cell transcription factors to initiate leukemia. Oncogene 40 (43) (2021)
David L Owen, Louisa E Sjaastad, Michael A Farrar
Regulatory T Cell Development in the Thymus. Journal of immunology (Baltimore, Md. : 1950) 203 (8) (2020)
David L Owen, Shawn A Mahmud, Louisa E Sjaastad, Jason B Williams, Justin A Spanier, Dimitre R Simeonov, Roland Ruscher, Weishan Huang, Irina Proekt, Corey N Miller, Can Hekim, Jonathan C Jeschke, Praful Aggarwal, Ulrich Broeckel, Rebecca S LaRue, Christine M Henzler, Maria-Luisa Alegre, Mark S Anderson, Avery August, Alexander Marson, Ye Zheng, Calvin B Williams, Michael A Farrar
Thymic regulatory T cells arise via two distinct developmental programs. Nature immunology 20 (2) (2019)
Bing Liu, Oscar C Salgado, Sangya Singh, Keli L Hippen, Jason C Maynard, Alma L Burlingame, Lauren E Ball, Bruce R Blazar, Michael A Farrar, Kristin A Hogquist, Hai-Bin Ruan
The lineage stability and suppressive program of regulatory T cells require protein O-GlcNAcylation. Nature communications 10 (1) (2019)
Emily A Irey, Chelsea M Lassiter, Nicholas J Brady, Pavlina Chuntova, Ying Wang, Todd P Knutson, Christine Henzler, Thomas S Chaffee, Rachel I Vogel, Andrew C Nelson, Michael A Farrar, Kathryn L Schwertfeger
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors. Proceedings of the National Academy of Sciences of the United States of America 116 (25) (2019)
Jason B Wong, Susannah L Hewitt, Lynn M Heltemes-Harris, Malay Mandal, Kristen Johnson, Klaus Rajewsky, Sergei B Koralov, Marcus R Clark, Michael A Farrar, Jane A Skok
B-1a cells acquire their unique characteristics by bypassing the pre-BCR selection stage. Nature communications 10 (1) (2019)
Eric P Rahrmann, Natalie K Wolf, George M Otto, Lynn Heltemes-Harris, Laura B Ramsey, Jingmin Shu, Rebecca S LaRue, Michael A Farrar, Susan K Rathe, Timothy K Starr, Michael A Farrar, Branden S Moriarity, David A Largaespada
Sleeping Beauty Screen Identifies RREB1 and Other Genetic Drivers in Human B-cell Lymphoma. Molecular cancer research : MCR 17 (2) (2018)
David L Owen, Shawn A Mahmud, Kieng B Vang, Ryan M Kelly, Bruce R Blazar, Kendall A Smith, Michael A Farrar
Identification of Cellular Sources of IL-2 Needed for Regulatory T Cell Development and Homeostasis. Journal of immunology (Baltimore, Md. : 1950) 200 (12) (2018)
Casey D S Katerndahl, Lynn M Heltemes-Harris, Mark J L Willette, Christine M Henzler, Seth Frietze, Rendong Yang, Hilde Schjerven, Kevin A T Silverstein, Laura B Ramsey, Gregory Hubbard, Andrew D Wells, Roland P Kuiper, Blanca Scheijen, Frank N van Leeuwen, Markus Müschen, Steven M Kornblau, Michael A Farrar
Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival. Nature immunology 18 (6) (2017)
Kamran Kaveh, Yutaka Takahashi, Michael A Farrar, Guy Storme, Marcucci Guido, Jamie Piepenburg, Jackson Penning, Jasmine Foo, Kevin Z Leder, Susanta K Hui
Combination therapeutics of Nilotinib and radiation in acute lymphoblastic leukemia as an effective method against drug-resistance. PLoS computational biology 13 (7) (2017)
Luke S Manlove, Jason M Schenkel, Kezia R Manlove, Kristen E Pauken, Richard T Williams, Vaiva Vezys, Michael A Farrar
Heterologous Vaccination and Checkpoint Blockade Synergize To Induce Antileukemia Immunity. Journal of immunology (Baltimore, Md. : 1950) 196 (11) (2016)

Michael A Farrar.css-eqlu8i{font-size:small;padding-left:4px;} (Michael A Linden)

Publication Activity (10 Years)

Top Topics

Top Venues

Michael A Farrar (Michael A Linden)